"Shorla Oncology’s IMKELDI approved by FDA for leukaemia cancers" was originally created and published by Pharmaceutical ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

The Institute for Clinical and Economic Review (ICER) has announced plans to assess the clinical efficacy and value of ...

In this randomized controlled trial, among adults diagnosed with chronic myeloid leukemia (CML), asciminib demonstrated a ...

For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase ...

As Ahmet F. Coskun and his team of researchers continue their mission to create a 3D atlas of the human body, mapping cells ...

The new report is an attempt to provide comprehensive safety data on the rapidly changing treatment landscape for relapsed or ...